Postacute Neurocognitive Sequelae Following Pediatric Chemotherapy: A Retrospective Study From the Montefiore Survivorship Clinic (2000-2024) [0.03%]
Aditi Vichare,Roham Hadidchi,Sonya Henry et al.
Aditi Vichare et al.
Purpose: Standard neurocognitive and imaging assessments in research settings may not fully capture the real-world symptom burden experienced by pediatric hematologic cancer survivors. We conducted a retrospective analysi...
Incidence, Risk Factors, and Impact of Immunotherapy on Brain Metastasis in Extensive-Stage Small Cell Lung Cancer Without Baseline Brain Involvement [0.03%]
Wenli Cao,Xiangjuan Ma,Weiheng Hu et al.
Wenli Cao et al.
Purpose: Brain metastasis is a frequent site of metastasis in extensive-stage small cell lung cancer (ES-SCLC). We investigated the incidence, risk factors, and the impact of immunotherapy on brain metastasis development ...
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39) [0.03%]
Allison M Deal,Yashasvini Sampathkumar,Brenda F Ginos et al.
Allison M Deal et al.
Purpose: Remote symptom monitoring using patient-reported outcomes (PROs) has been shown to improve symptom control and physical function among patients with advanced cancer. However, it is unclear whether these benefits ...
Evolution of Electronic Health Records in Support of Cancer Care: Challenges and Opportunities [0.03%]
癌症电子健康档案的发展：机遇与挑战
Lawrence N Shulman
Lawrence N Shulman
Video Education With Clinical Genetic Testing Coordinators for the Rapid Evaluation of Patients With Cancers: Real-World Evidence [0.03%]
临床遗传学检测协调员视频教育对癌症患者的快速评估：真实世界证据
Jill E Stopfer,Miki Horiguchi,Anu Chittenden et al.
Jill E Stopfer et al.
Purpose: Germline genetic testing is critical for guiding cancer treatment, identifying hereditary syndromes, and enabling cascade testing for at-risk relatives. However, barriers such as limited access to genetic counsel...
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer [0.03%]
奥希替尼与二代表皮生长因子受体酪氨酸激酶抑制剂治疗转移性表皮生长因子受体突变型非小细胞肺癌的生存率、毒性及经济结果比较研究
Po-Huang Chen,Hong-Jie Jhou,Wei-Cheng Chang et al.
Po-Huang Chen et al.
Purpose: Direct real-world comparisons between osimertinib and second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are lacking, particularly regarding the comparative effectiveness,...
Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522 [0.03%]
KEYNOTE-522研究中三阴性乳腺癌患者接受治疗后的真实世界安全性分析
Mara Lacy Hofherr,Andrew A Davis,Spenser January et al.
Mara Lacy Hofherr et al.
Purpose: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Early-stage, high-risk patients with TNBC are treated with chemotherapy and pembrolizumab per the KEYNOTE-522 regimen. This report e...
Blase Polite,Niharika Dixit,John Hennessy et al.
Blase Polite et al.
Characterizing Relationships Between Daily Pain, Opioid Use, and Mood in Patients With Advanced Cancer Using Ecological Momentary Assessments [0.03%]
基于生态瞬时评估技术表征晚期癌症患者的每日疼痛、阿片类药物使用和情绪之间的关系
Jian Zhao,Meng Chen,Kristin L Schreiber et al.
Jian Zhao et al.
Purpose: In advanced cancer, pain symptoms, opioid use, and cognitive-emotional processes fluctuate day to day and may mutually reinforce one another. We used 28-day ecological momentary assessments (EMAs) to quantify wit...
Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple Myeloma [0.03%]
老年多发性骨髓瘤患者免疫调节药物依从性变化及其对生存期的影响
Rong Wang,Mengmeng Ji,Natalia Neparidze et al.
Rong Wang et al.
Purpose: Immunomodulatory agents (IMiDs) are critical in treating multiple myeloma (MM). We aimed to identify patterns of adherence to IMiD treatment, patient characteristics associated with adherence, and the correspondi...